Skip to content

Multicentre REtrospective StuDy of Treatment and OUtComes in STEMI Patients in Fujian Province

Multicentre REtrospective StuDy of Treatment and OUtComes in ST-elevatION Myocardial Infarction(STEMI) Patients in Fujian Province

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03763968
Acronym
REDUCTION
Enrollment
7000
Registered
2018-12-04
Start date
2014-01-01
Completion date
2018-12-31
Last updated
2019-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-segment Elevation Myocardial Infarction

Brief summary

This is a multicentre observational study planned to gather follow up data for a period of 1 year in order to understand the treatments and outcomes of ST-segment elevation myocardial infarction(STEMI) and improve medical care quality in Fujian province for China. Consecutive patients who were admitted and diagnosed with STEMI between January 2014 December 2018 were conducted at five regional representative hospitals in Fujian province, which included the Fujian Provincial Hospital,Longyan First Hospital, the affiliated hospital of putian university,the Second Affiliated Hospital of Fujian Medical University and Mindong Hospital of Ningde City.

Interventions

OTHERtreatment and outcome

Sponsors

Yan-song Guo
Lead SponsorOTHER
Longyan City First Hospital
CollaboratorOTHER
The Affiliated Hospital of Putian University
CollaboratorOTHER
The Second Affiliated Hospital of Fujian Medical University
CollaboratorOTHER
The MinDong Hospital of Ningde City
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* STEMI patients with symptom onset within 30 days

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortality5yearsall mortality,cardiovascular mortality

Secondary

MeasureTime frameDescription
other in-hospital complications5yearsrecurrent myocardial infarction, target vessel revascularization,contrast-induced acute kidney injury,stroke,bleeding,and so on
MACEs for long-term follow up1 yearmortality,stent restenosis, recurrent myocardial infarction, and target vessel revascularization,stroke,bleeding,and so on

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026